| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84054-005-60 | 84054-005 | HUMAN PRESCRIPTION DRUG | ZUNVEYL | benzgalantamine | TABLET, DELAYED RELEASE | ORAL | 20240809 | N/A | NDA | NDA218549 | Alpha Cognition, Inc. | BENZGALANTAMINE | 5 mg/1 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (84054-005-60) |
| 84054-015-60 | 84054-015 | HUMAN PRESCRIPTION DRUG | ZUNVEYL | benzgalantamine | TABLET, DELAYED RELEASE | ORAL | 20240809 | N/A | NDA | NDA218549 | Alpha Cognition, Inc. | BENZGALANTAMINE | 15 mg/1 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (84054-015-60) |
| 84054-010-60 | 84054-010 | HUMAN PRESCRIPTION DRUG | ZUNVEYL | benzgalantamine | TABLET, DELAYED RELEASE | ORAL | 20240809 | N/A | NDA | NDA218549 | Alpha Cognition, Inc. | BENZGALANTAMINE | 10 mg/1 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (84054-010-60) |